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Abstract
GPR3 is an orphan G protein-coupled receptor endowed with constitutive Gs signaling activity, which is expressed broadly
in the central nervous system, with maximal expression in the habenula. We investigated the consequences of its genetic
deletion in several behavioral paradigms and on neurotransmission. Compared to wild-type, hippocampal neurons from
Gpr3
2/2 mice displayed lower basal intracellular cAMP levels, consistent with the strong constitutive activity of GPR3 in
transiently transfected cells. Behavioral analyses revealed that Gpr3
2/2 mice exhibited a high level of avoidance of novel and
unfamiliar environment, associated with increased stress reactivity in behavioral despair paradigms and aggressive behavior
in the resident-intruder test. On the contrary, no deficit was found in the learning ability to avoid an aversive event in active
avoidance task. The reduced ability of Gpr3
2/2 mice to cope with stress was unrelated to dysfunction of the hypothalamic-
pituitary-adrenal axis, with Gpr3
2/2 mice showing normal corticosterone production under basal or stressful conditions. In
contrast, dramatic alterations of monoamine contents were found in hippocampus, hypothalamus and frontal cortex of
Gpr3
2/2 mice. Our results establish a link between tonic stimulation of the cAMP signaling pathway by GPR3 and control of
neurotransmission by monoamines throughout the forebrain. GPR3 qualifies as a new player in the modulation of
behavioral responses to stress and constitutes a novel promising pharmacological target for treatment of emotional
disorders.
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Introduction
How signal transduction pathways control different aspects of
behavior is a central issue in neurobiology. Recently, the cAMP
signaling pathway has been implicated in the action of
chronically administrated antidepressant drugs [1]. In addition,
alterations in the cAMP pathways have been reported to
produce major disturbances in emotional behaviors [2,3,4,5].
Here, we examine the implication of GPR3, a novel potentially
important regulator of intraneuronal cAMP, in the modulation
of emotional behavior.
GPR3 is an orphan G-protein-coupled receptor (GPCR) which,
upon transfection in various mammalian cell lines, causes strong
constitutive activation of adenylyl cyclase, in the absence of any
added agonist [6]. In mouse oocytes, GPR3 contributes to
maintenance of cAMP concentrations at a level required to
ensure meiotic arrest in prophase I until the LH surge [7,8,9].
Whether cAMP accumulation is the result of a true constitutive
activity of the receptor or the consequence of the chronic
stimulation by a ubiquitous unknown ligand, is still debated.
Sphingosine 1-phoshate was proposed as an agonist of the rat
GPR3 homologue [10,11] but this has not been confirmed yet.
GPR3 transcripts are also widely expressed in the mouse brain,
in areas related to different physiological functions. More
specifically, GPR3 receptor is expressed in the main brain
structures involved in stress-related behaviors such as habenula
but also hippocampus, amygdala, limbic system and cortex.
Interestingly, the highest levels of expression were found in the
habenula. The habenular complex is an important relay station
between the limbic forebrain and the midbrain. It has been clearly
shown to participate in the regulation of ascending monoamine
and acetylcholine transmission towards hippocampus and frontal
cortex [12,13]. Serotonin and noradrenaline systems are known to
play a role in the regulation of several central activities including
mood and anxiety. Dysregulation of these systems appears to have
a role in the pathophysiology of depression and anxiety disorders
[14,15]. Given the ability of GPR3 to activate the cAMP
regulatory cascade in a tonic way in areas involved in stress-
related behaviors, we hypothesized that GPR3 could play a role in
the control of the corresponding behavioral responses.
In the present study, we have directly addressed this issue by
analyzing the behavioral phenotype of Gpr3
2/2 mice generated by
homologous recombination, focusing on the evaluation of
responses related to emotional behavior. The relevance of this
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hormonal modulation of the hypothalamic-pituitary adrenal axis
and the monoamines neurotransmission in the brain.
Materials and Methods
Generation of Gpr3
2/2 mice and animal handling
The generation of Gpr3
2/2 mice and their genotyping by
polymerase chain reaction (PCR) amplification of tail DNA were
described previously [7]. Heterozygous progeny were backcrossed
with CD1 females for 12–17 generations before generating the
Gpr3
2/2 and Gpr3
+/+ founders. Experimental Gpr3
2/2 and Gpr3
+/+
mice were generated by a syngenic cross between founders.
All experiments were performed under blind conditions.
Knockout and wild-type control males (25–30 g) were housed
five per cage in temperature- (2161uC) and humidity- (55610%)
controlled rooms with a 12-h light/12-h dark cycle (light between
8:00 AM and 8:00 PM). Food and water were available ad libitum
during all experiments. Animal procedures were conducted in
accordance with the guidelines of the European Communities,
Directive 86/609/EEC regulating animal research and approved
by the local ethical committee (CEEA-PRBB).
Drugs
Fluoxetine hydrochloride (Sigma Chemical Co, Madrid, Spain)
was dissolved in distillate water and diazepam in saline (0.09%).
Both compounds were administered by intraperitoneal (i.p.) route
30 min before the test. The volume of injection was 0.1 ml per
10 g body weight. Control animals received the corresponding
vehicle.
Reverse transcription – polymerase chain reaction
Poly(A)+ RNA was extracted from tissues using the Fast Tract
RNA purification kit (Invitrogen, Carlsbad, CA) and was reverse
transcribed with Superscript II (Invitrogen, Carlsbad, CA) using
oligo (dT) 12–18 primers. Primers as well as PCR reactions
parameters were as shown in Table S1.
In situ RNA hybridization
Digoxigenin-labeled RNA probe for GPR3 was obtained by
reverse transcription of mouse genomic DNA corresponding to
nucleotides 843–1491 (GenBank accession number D21062). After
fixation by cardiac perfusion with 4% paraformaldehyde in PBS,
brains were cryoprotected in sucrose 30%, frozen on dry ice, and
20 mm cryosections were cut and mounted on superfrost slides. In
situ hybridization was performed as described previously [16].
Behavioral responses
All experiments were conducted during the light cycle with
naive male mice between 2 and 6 months of age. Animals were
previously habituated to the testing rooms and handled for one
week prior starting the experiments.
Locomotor activity. Mice were placed individually in
locomotor activity boxes, consisting of a plastic rectangular area
(9 cm620611 cm) with two crossed photocells, isolated in a
soundproof furniture and in almost complete darkness (,5 lux)
(Imetronic, Lyon, France). The number of activity counts was
evaluated during 60 min on the testing day starting at 10.00 AM.
Open-field test. This method was used to evaluate
locomotion under stressful situation. Briefly, each animal was
placed in the open-field apparatus consisting of a rectangular area
(70 cm wide690 cm long660 cm high) under bright illumination
(500 lux). Sixty-three squares (10 cm610 cm) were drawn with
black lines on the floor of the apparatus. The parameters were
measured during observation sessions of 5 min for three
consecutive days. Two objects were placed in the field (a
marble, 5.5 cm high, and a plastic figure, 4.5 cm high)
exclusively on day 1 and the time spent to explore these two
objects was recorded. Experiments were performed from 9.00 AM
to 2:00 PM.
Skill learning and motor coordination on rota-
rod. Animals were placed gently onto a rod of the rota-rod
device. The speed of the rod was accelerated from 4 RPM to 20
RPM (acceleration 1 RPM/seconds) and kept constant until the
end of the trial. We registered the time until the animal fell down.
The cut-off time was 90 seconds. The animals were tested until
they showed no further improvement in the performance, which
means the variation between three consecutive trials was less than
30%. We expressed the speed of learning as the number of trials
(with 95% confidence intervals, CI) necessary to reach 50% of the
maximal performance.
Elevated plus-maze. This apparatus consisted of a plastic
maze with four arms (16 cm long65 cm wide) set in cross from a
neutral central square (5 cm65 cm). Two opposite arms were
delimited by vertical walls (closed arms) whereas the two opposite
arms had unprotected edges (open arms). The maze was elevated
30 cm above the ground and placed in indirect light (100 lux).
Each mouse was placed in the central zone facing one of the open
arms and was observed during 5 min for three consecutive days.
An arm visit was recorded when the mouse moved all four paws
into the arm. The total number of visits into the closed arms, open
arms and the cumulative time spent in the open arms and closed
arms were registered through a video camera system (Viewpoint,
Lyon, France). The percentage of time spent and the percentage of
entries in the open arms were then calculated for each animal. In a
second experiment the anxiolytic effect of diazepam was evaluated
in a group of naive mice. Diazepam was administered by i.p.
route, 30 min before the test. The test was conducted exactly as
described above.
Resident-intruder procedure. In this model, resident and
intruder mice were put together for a period of 4 min. The attack
score was calculated by registering the presence of an attack or
menace (beating tail) by the resident for each 10-s period during
the total 4-min period. The latency time (s) for the first attack was
also registered. Resident mice were housed individually for
10 weeks prior to the beginning of the experimental procedure.
Intruder animals were housed five per cage. Intruder and resident
animals were carefully matched in age and weight. Animals
received two training sessions in the morning and two tests sessions
in the afternoon [17].
Forced swim test. This model was performed as previously
reported [18]. Each mouse was placed in a transparent plastic
cylinder filled with water (2261uC) and submitted to a forced
swim during 6 min. The total duration of immobility, including
small maintenance movements, was measured during the last
4 min of the test.
Tail suspension test. A modified version of the previously
described [19] was used in our experiments. Mice were
individually suspended by the tail to a horizontal ring-star bar
(distance from floor was 35 cm) using adhesive tape (distance from
tip of tail was 2 cm). The recorded parameter was the cumulative
number of seconds spent immobile during a total time of 6 min.
Active avoidance procedure. Mice were trained to avoid an
aversive unconditioned stimulus (US) associated with a
conditioned stimulus (CS, light) in a two-way shuttle box
apparatus [20]. The US was an electric shock (0.2 mA)
continuously applied to the grid of the floor. The apparatus
(Panlab, Barcelona, Spain) consisted of a box with two
Gpr3 KO and Behavior.
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preceded by 5 s the onset of the US and overlapped it for 25 s.
By using this procedure, the light was presented in the
compartment for 30 s, and at the end of this period, both CS
and US were turned off. A conditioned response was recorded
when the animal avoided the US by leaving the compartment
within the 5 s after the onset of the CS. There was an inter-trial
interval of 30 s between each trial session. Mice were subjected to
once daily 100-trial active avoidance sessions during 5 consecutive
days. A learning index was calculated for each animal and session
by the ratio between the number of conditioned changes and the
number of inter-trial changes of compartment to avoid potential
influence of locomotor activity. The basal reactivity to electric
foot-shock exposure was evaluated in a preliminary experiment in
a separate group of Gpr3
2/2 and Gpr3
+/+ mice in order to avoid
biased responses due to changes of locomotion and/or nociceptive
sensitivity.
Corticosterone levels measurement
Serum corticosterone levels from blood collected after decap-
itation, were measured by using the Coat-A-CountH Rat
Corticosterone (Diagnostic Product Corporation, Los Angeles,
CA, USA) as described previously [21].
HPLC determination of endogenous catecholamine and
indolamine content
Levels of monoamine neurotransmitters and their metabolites 3-
methoxytyramine (3-MT), homovanillic acid (HVA), normeta-
nephrine (NM) and 5-hydroxy indolacetic acid (5-HIAA) were
determined by high performance liquid chromatography (HPLC)
coupled with electrochemical and ultraviolet detection, according
to the method described elsewhere [22]. More detailed informa-
tion is provided in Materials and Methods S1.
Construction of N terminus Rhodopsin-Tagged receptors
The addition of a tag corresponding to the first 19 amino acids
of bovine rhodopsin at the amino terminus of the receptors allows
assessment of surface expression with a tag-specific monoclonal
antibody. The coding region of human Gpr3 (NM005281: 96–
1096) was swapped with the EcoRI - BamHI I486F hTSH
fragment in SP-RT-I486F hTSH- pcDNA3 plasmid previously
described in [23].
Transfection Experiments
Chinese Hamster ovary (CHO-K1) cells cultured in Ham’s F12
medium (Invitrogen, Merelbeke, Belgium), were used for transient
expression experiments. They were transfected using the Fugene 6
reagent method (Roche, Indiapolis, IN) according to the
manufacturer’s instructions. Briefly, 2 10
6 cells were seeded in
10-cm Petri dishes at day 1 and transfected with 5.5 mg ADN at
day 2. At day 3, cells were detached by trypsinization and seeded
in 24-well (2 10
5/well) and 96-well plates (5 10
4/well). At day 4,
cells were used for flow immunofluorometry (24-well) and cAMP
determinations (96-well). To determine the intracellular cAMP,
medium was replenished with 25 ml of fresh culture medium
containing 25 mM rolipram (Sigma, Bornem, Belgium) for 30 min.
The reaction was terminated by adding 25 ml of lysis buffer.
Quantitative cAMP determinations were made using the cAMP
femto 2 bulk HTRF kit (Cisbio, Bagnols, France) according to
manufacturer’s manual. Triplicate wells were used for each assay.
Non-transfected cells and cells transfected with the empty
pcDNA3 were always run as negative controls. To find a linear
relation between the number of receptors present at the cell
surface and the cAMP accumulation, variable amounts of SP-RT
hGpr3-pcDNA3 or SP-RT I486F hTSH-pcDNA3 constructs,
completed with pcDNA3 vector to the same final DNA quantity,
were transfected. SP-RT I486F hTSH is a mutant hTSH receptor
endowed with strong constitutive activity. This linearity as well as
a similar level of expression for both receptors were achieved when
transfecting 0.1% of GPR3 or 1% of I486F TSH receptors in
vector alone. The experiments were reproduced five times.
Sphingosine-1-phosphate (Biomol, Plymouth Meeting, PA) was
prepared following the manufacturer’s instructions and used at a
final concentration of 10 mM in 0.032% fatty acid free Bovine
Serum Albumine (Sigma, Bornem, Belgium) in Ham’s F12
medium (mock).
Quantification of Cell Surface Expression of GPR3 by Flow
Immunocytometry
After detachment the cells were centrifuged at 5006g for 3 min
at 4uC and the supernatant was discarded. They were then
incubated for 30 min at room temperature in 100 ml PBS-BSA
0.1% containing the OR2-15A-6 monoclonal antibody directed
against the N-terminus of bovine rhodopsin [24]. Cells were then
washed with 2 ml PBS-BSA 0.1% and centrifuged as described
above. They were incubated on ice in the dark for 30 min with
fluoresceine-conjugated c-chain-specific goat antimouse IgG
(Sigma, St Louis, MO) in the same buffer. Propidium iodide
(10 mg/ml) was used for detection of damaged cells that were
excluded from the analysis. Cells were washed as described above
and resuspended in 250 ml PBS-BSA 0.1%. The fluorescence of
10,000 cells per tube was assayed by a FACScan Flow
cytofluorometer (Becton Dickinson, Eerenbodegem, Belgium).
Hippocampal cell culture and cAMP measurement
The results reported below were collected from five different
litters, each experiment was made with Gpr3
+/+ and Gpr3
2/2
newborn mice of both sexes, born and prepared for culture on the
same day. Gpr3
+/+ and Gpr3
2/2 mice were decapitated on the day
of birth. Their brains were removed and placed in chilled (4uC)
Leibovitz L15 medium enriched with 0.6% glucose. Tissue was
mechanically dissociated with a fire-polished pipette into individ-
ual cells. Cells were collected by centrifugation, resuspended in
Neurobasal-A supplemented with B27 and N2 (Invitrogen,
Merelbeke, Belgium). 10
6 cells from each hippocampus were
plated in duplicate into a well of a 24-well plate precoated with
Poly-D-lysine (Becton Dickinson, Erembodegem, Belgium) and
maintained in a humidified incubator at 37uC with 95%
atmospheric air/5% CO2. To determine the intracellular cAMP,
24 h after, medium was replenished with fresh culture medium
containing 25 mM rolipram (Sigma, Bornem, Belgium) for 30 min.
The reaction was terminated by aspirating the medium, adding
500 ml of 80% ethanol and placing at room temperature for
15 min. The extracts were lyophilized and reconstituted for cAMP
level measurement using the cAMP femto 2 bulk HTRF kit
(Cisbio, Bagnols, France) according to manufacturer’s manual.
Cultures were made in duplicate for each hippocampus. Results
are calculated as the mean of minimum two dilutions in the linear
part of the standard curve. Immunochemistry is described in
Materials and Methods S1.
Statistical Analysis
Data from behavioral studies were analyzed using a two-way
Anova with repeated measures for the experiments on open-field
test, elevated plus maze and the active avoidance paradigm. For
these studies the factors of variation were genotype (between
Gpr3 KO and Behavior.
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forced swimming test and the evaluation of the diazepam effects
on the elevated plus maze, two- way Anova were calculated. The
factors of variation were genotype (between subjects) and
treatment (between subjects). Corticosterone assay was analyzed
by calculating a two-way Anova with genotype (between subjects)
and stress exposure (between subjects) as variables. One-way
Anova was calculated for genotype effect for data from intruder
test as well as horizontal and vertical locomotor activities.
Subsequent one-way Anova were calculated when required. Data
from monoamine measurements were analyzed by using the
Student t-test and cAMP levels with the Mann-Withney test. The
level of significance was p,0.05.
Results
Gpr3
2/2 mouse model
To investigate the role of GPR3 in the brain we generated a
mutant mouse line (Gpr3
2/2) with a deletion encompassing the
entire coding sequence of Gpr3. In the course of the present study
mutant females were found to display important problems of
fertility, which were described in detail elsewhere [7]. However,
Gpr3
2/2 mice were viable and exhibited neither obvious
developmental defects nor gross neurological alterations. The
absence of Gpr3 transcripts in Gpr3
2/2 mice was confirmed by
reverse transcription (RT) polymerase chain reaction (PCR) on
adult brains (see Figure S1). In agreement with previous studies
[25] we found, by in situ hybridization, that GPR3 is widely
expressed in several brain areas, with the highest levels in the
habenula. Gpr3 was also expressed diffusely throughout the
cerebral cortex (in particular in sub- and supragranular layers),
the striatum, and the hippocampus (including CA1, CA3 and
dentate gyrus) (Figure 1).
Increase in anxiety-like and despair-like behaviors,
reaction to stress and aggressiveness in Gpr3
2/2 mice
The effects of Gpr3 inactivation on spontaneous behaviors and
on reactions related to stress were analyzed. No difference between
genotypes was found when exploratory activity was evaluated
under non-stressful conditions (Figure 2A). Indeed, one-way
Anova did not show genotype effect for horizontal nor vertical
locomotor activities. However, under stressful conditions in the
open-field test, Gpr3
2/2 mice displayed a decrease in exploratory
behavior relative to wild-type on day 1 and day 2 of the test when
the animals were not yet habituated to the environment. The
number of squares crossed in the arena was lower in Gpr3
2/2 mice
(Figure 2B). Two-way Anova showed a significant effect of the day
(F(2, 68)=40.021, p,0.01); the genotype (F(1, 34)=9.366, p,0.01)
and interaction between these two variables (F(2, 68)=7.848,
p,0.01). In addition, the number of squared crossed in the central
area of the open-field was lower for the Gpr3
2/2 mice [Figure 2C;
dayeffect,(F(2,68)=7.956,p,0.01);genotypeeffect(F(1, 34)=168.518,
p,0.01), with no significant interaction between these factors]. The
number of entries in the center of the field was also lower for the
mutant mice [Figure 2D; day effect, (F(2, 68)=14,123, p,0.01);
genotype effect, (F(1, 34)=128.071, p,0.01, without significant
interaction between these two variables]. In agreement, the
percentage of time spent in the central area was significantly
lower in the Gpr3
2/2 mice on days 1, 2 and 3 [Figure 2E;
genotype effect (F(1, 34)=162.1, p,0.01), and day effect (F(2,
68)=8.824, p,0.001) without interaction between these two
factors]. Mice also exhibited a decreased exploration of
unknown objects (F(1, 34)=8.104, p,0.01), thereby showing a
clear neophobia and thigmotaxis (Figure 2F). Together these
results suggested that Gpr3
2/2 mice displayed increased
behavioral inhibition in a stressful novel environment, indicating
an altered response to stressful events and/or an anxiety-like
phenotype. The observed changes were not due to impaired
motor coordination or altered skill tasks learning in Gpr3
2/2
mice since both genotypes exhibited similar performance in the
rota-rod test (Gpr3
+/+ 8.20 trials, CI 6.037–10.363; Gpr3
2/2
9.00 trials, CI 6.108–11.892). Half maximal performance was
reached after similar number of trials in Gpr3
+/+ and Gpr3
2/2
animals, indicating that both genotypes had similar speed of
learning. The anxiogenic-like phenotype was confirmed by the
results obtained in the elevated plus-maze (Figure 3A, B). In this
test, mice face a conflict between an aversion to the open arms
of the maze and the motivation to explore them. Gpr3
2/2 mice
displayed a decrease in the percentage of entries and time spent
in the open arms of the maze on the three observation days
Figure 1. Expression of GPR3 in adult brain. In situ hybridization
performed on Gpr3
+/+ and Gpr3
2/2 adult brain coronal sections,
showing selective expression of Gpr3 in the habenula (hb), and diffuse
expression throughout the cerebral cortex (ctx), striatum (st), and layers
of pyramidal cells in the hippocampus (hc). No hybridization signal
could be detected in any brain region of Gpr3
2/2 mice.
doi:10.1371/journal.pone.0004704.g001
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theopenarmshowedasignificanteffectoftheday(F(2, 128)=73.441,
p,0.01) and the genotype (F(1, 64)=82.374, p,0.01) without
interaction between these two factors. In the same way, two-way
Anova for the entries in the open arm detected a significant effect of
theday(F(2, 128)=8.194,p,0.01)andthegenotype(F(1, 64)=109.185
p,0.01) but no significant interaction emerged. The anxiety-like
responsesobservedintheelevatedplus-mazeweresimilarlyreversed
by diazepam administration (1 mg/kg) in both genotypes. Indeed
two-wayAnovacalculatedforthetimespentintheopenarmshowed
a significant effect for the genotype (F(1, 38)=8.074, p,0.01) and
treatment(F(1,38)=8.208,p,0.01)withoutinteractionbetweenthese
two factors (Figure 3C). In addition, at the dose used (1 mg/kg, ip),
diazepam did not induce significant changes in locomotor activity
since the number of entries in the open arm was not significantly
differentinanimalstreated withthebenzodiazepine(Figure 3D).To
investigate whether their anxiety-like behavior was associated with
aggressiveness, we evaluated Gpr3
2/2 mice in the resident-intruder
test. Gpr3
2/2 resident male mice exhibited a higher aggressiveness
towards intruders than wild-type mice as estimated by their higher
aggressiveness score in two sessions (session 1, F(1, 20)=4.016,
p,0.01; session 2 (F(1, 19)=4.016, p,0.05), and their shorter latency
period for the first attack (F(1, 20)=4.501, p,0.05) (Figure 4A). We
next examined the Gpr3
2/2 profiles in two different behavioral
paradigmswidelyused toassessbehavioraltraitsthat maybe related
to despair behavior, the forced swim and the tail suspension tests.
Both tests arebased on the assumption that micewill normallytryto
escape from an inescapable aversive stimulus. An enhanced
immobility is thought to represent a state of behavioral despair that
is characteristic of depression [26,27]. Gpr3
2/2 mice exhibited an
increase in the duration of immobility compared with wild-type mice
inbothbehavioralmodels.Asexpected,administrationoftheinhibitor
of serotonin reuptake fluoxetine (10 mg/kg, i.p., 30 min before the
test) reduced the period of immobility of wild-type mice in both tests
([27];Figure4B,C).Gpr3
2/2miceappearedtobesensitivetothisdose
of fluoxetine since its administration abolished statistical difference
between genotypes in both tests. Two-way Anova for the forced swim
testshowedasignificanteffectfortreatment(F(1, 39)=175.05,p,0.01)
Figure 2. Spontaneous exploratory behavior in Gpr3
2/2 mice. Spontaneous horizontal and vertical locomotor activity under non-stressful
conditions in both genotypes (n Gpr3
2/2=10; n Gpr3
+/+=10) (A). Locomotor activity in the open-field apparatus under stressful conditions (Gpr3
2/2
n=17; Gpr3
+/+ n=18) (B–F). Different parameters were observed during a 5 min-session: number of squares crossed (B), squares crossed in the central
area (C), entries to the central area of the field (D), percentage of time spent in the central area (E) and the time spent exploring objects placed in the
middle of the field on day one (F). Open bars and circles represent Gpr3
+/+; black bars and circles represent Gpr3
2/2 mice. Black stars, genotype
comparison. One star, p,0.05; two stars, p,0.01 (one-way ANOVA).
doi:10.1371/journal.pone.0004704.g002
Figure 3. Increased anxiety-like responses in Gpr3
2/2 mice are
reversed by diazepam. Gpr3
2/2 and Gpr3
+/+ mice were evaluated in
the elevated plus-maze test. Animals were tested on three consecutive
days (D1, D2 and D3; Gpr3
2/2 n=32; Gpr3
+/+ n=34) (A, B). The
parameters evaluated were the percentage of time spent in the open
arms (A) and the percentage of entries in the open arms (B). Open bars
represent Gpr3
+/+; black bars represent Gpr3
2/2 mice. The anxiety-like
responses in the elevated-plus maze were measured after administra-
tion of vehicle or diazepam (1 mg/kg), 30 min before the test (Gpr3
2/2
n=10–12; Gpr3
+/+ n=9–11) (C, D). Black stars, genotype comparison
(one-way ANOVA); white star, treatment comparisons (one-way
ANOVA). One star, p,0.05; two stars, p,0.01.
doi:10.1371/journal.pone.0004704.g003
Gpr3 KO and Behavior.
PLoS ONE | www.plosone.org 5 March 2009 | Volume 4 | Issue 3 | e4704and interaction between treatment and genotype (F(1, 39)=10.497,
p,0.01) but no genotype effect. For the tail suspension, two-
way Anova revealed a significant effect for treatment (F(1,
39)=16.254, p,0.001) and genotype (F(1, 39)=11.255, p,0.01)
but no significant interaction emerged. Since dysregulation of
the hypothalamic-pituitary adrenal (HPA) axis can lead to the
onset of anxiety-like behavior and depression, we compared in
Gpr3
2/2 and wild-type mice the levels of serum corticosterone,
the major glucocorticoid end product in rodents, both under
basal conditions and in response to the stress induced by the
tail suspension test. The basal corticosterone levels were
comparable in both genotypes (Figure 4D). In addition,
corticosteronelevels were similarly increased after stress despite
the significant increase in the duration of immobility observed
for Gpr3
2/2 mice (Figure 4D). Two-way Anova calculated for
genotype and stress exposure revealed a stress effect (F(1,
38)=14.489, p,0.01) with neither genotype effect nor interac-
tion between the two factors. We next investigated if the
altered emotional-like state exhibited by the knockouts, could
alter their learning ability in an active avoidance paradigm. In
this task the mouse has to learn to avoid an aversive event in
response to a stimulus cue, by actively moving to a different
compartment. The electric foot-shock used as aversive stimulus
was found to produce similar basal reactivity in both genotypes
as evaluated, in a preliminary experiment, by the changes of
compartment, locomotor activity, jumps and vocalizations (data
not shown). Gpr3
2/2 and Gpr3
+/+ exhibited a similar progressive
increaseintheavoidancelearningperformancethroughthefivedays
of training as assessed by the significant increase in the number of
conditioned changes inboth genotypes (Figure 4E). Two-way Anova
revealed a significant effect for the day (F(4, 112)=82,602,p,0.01)
but neither genotype effect nor interaction between the two
variables. Therefore, the lack of GPR3 does not seem to prevent
the knockouts from adapting themselves to adverse conditions in this
paradigm.
Monoamine neurotransmitter levels are altered in
multiple brain areas in Gpr3
2/2 mice
Given the high expression of Gpr3 in the habenula, which is
involved in the monoamine regulation [12], we determined
whether differences in monoaminergic neurotransmission may
underline the behavioral alterations in Gpr3
2/2 mice. We
measured levels of dopamine (DA), noradrenaline (NE) and
serotonine (5-HT) and their metabolites 3-methoxytyramine (3-
MT), homovanillic acid (HVA), normetanephrine (NM) and 5-
hydroxy indolacetic acid (HIAA) in the amygdala, hippocampus,
hypothalamus, striatum and frontal cortex in knockout and wild-
type littermates. 5-HT and NE were significantly reduced in the
hypothalamus and frontal cortex (Figure 5A, B). DA and 5-HT
were also found dramatically reduced in the hippocampus
(Figure 5C). Among the metabolites, HIAA, the major metabolite
of 5-HT and 3-MT, the primary metabolite of DA were
significantly reduced, whereas NM, the primary metabolite of
NE was elevated in all three regions (Figure 5A, B, C). In addition
HVA, the secondary metabolite of DA was also significantly
reduced in the frontal cortex (Figure 5B). No differences between
genotypes were found in striatum and amygdala (not shown).
These changes in monoamine neurotransmitters content could
support the behavioral alterations observed in Gpr3
2/2 mice.
Inability of sphingosine 1-P to affect GPR3 constitutive
basal activity
In an attempt to link the phenotype of Gpr3
2/2 animals with
the regulation of GPR3 activity, we re-explored the role of
sphingosine 1-P, previously proposed as a possible agonist of the
receptor [11]. We measured the cAMP accumulation induced by
transient expression of a Gpr3 plasmid in CHO cells in basal
conditions and in presence of 10 mM sphingosine 1-P. cAMP
levels were compared with those of the highly constitutively active
I486F TSH receptor mutant [23]. In order to compare cAMP
accumulation at similar level of expression for both receptors and
Figure 4. Increased despair responses in Gpr3
2/2 mice. Gpr3
2/2 and Gpr3
+/+ mice were evaluated in different behavioral paradigms. For the
resident-intruder test, an aggressiveness score was calculated in the two first sessions (S1 and S2) and the latency period (s) of the first attack was
registered (Gpr3
2/2 n=12; Gpr3
+/+ n=13) (A). The duration of immobility in the forced swim test (Gpr3
2/2 n=9;Gpr3
+/+ n=11) (B) and in the tail
suspension test (Gpr3
2/2 n=12; Gpr3
+/+ n=13) (C) was measured after receiving vehicle or fluoxetine (10 mg/kg), 30 min before the test. Serum
corticosterone levels (ng/ml) were measured under basal condition and after exposure to the tail suspension test (n=9–10) (D). The learning
performance was evaluated in the active avoidance paradigm on five consecutive days (D1 to D5; Gpr3
2/2 n=14; Gpr3
+/+ n=16). Learning index was
calculated as the ratio between the conditioned responses and the inter-trial changes (E). Open bars and circles represent Gpr3
+/+; black bars and
circles represent Gpr3
2/2 mice. Black stars, genotype comparison (one-way ANOVA); white star, treatment comparisons (Scheffe’s F-test). One star,
p,0.05; two stars, p,0.01.
doi:10.1371/journal.pone.0004704.g004
Gpr3 KO and Behavior.
PLoS ONE | www.plosone.org 6 March 2009 | Volume 4 | Issue 3 | e4704under conditions in which cAMP accumulation is proportional to
expression, we transfected 0.1% of GPR3 or 1% of I486F TSH
receptor constructs diluted in the empty vector.
As expected, the expression of GPR3 resulted in a dramatic
stimulation of cAMP accumulation. Noteworthy, this effect was
observed in cells cultured in serum-free medium. The stimulation
amplitude was comparable to that observed with the I486F TSH
receptor when normalized to surface expression (Figure 6A).
cAMP accumulation in mock condition (0.032% fatty acid free
Bovine Serum Albumine in serum free Ham’s F12 medium) was
unaffected after a one-hour incubation with 10 mM sphingosine 1-
P (Figure 6A) thereby refuting, in our hands, its previously
described agonist properties [11].
Decrease of intracellular cAMP levels in primary
hippocampal culture of Gpr3
2/2 mice
Although the consequence of the absence of GPR3 on fertility
was shown to be directly correlated with a decrease in oocyte
cAMP [9,10], there are no data connecting endogenous GPR3
expression with cAMP production in the CNS. Therefore, we
decided to evaluate modifications of cAMP levels in the brain. For
this purpose, we measured the basal cAMP levels in primary
cultures of newborn Gpr3
+/+ and Gpr3
2/2 hippocampal neurons
24 h after plating. RT PCR experiments confirmed the Gpr3
expression in Gpr3
+/+ culture (Figure 6B). Basal cAMP levels were
found decreased in Gpr3
2/2 mice compared with wild-type
(p,0.001; Figure 6C). The percentages of neuronal cells were
evaluated by the number of cells immunostained using the
antibodies TUJ1 directed against b-tubulin neuronal isoform III
and Ctip2, a transcriptional repressor that is highly expressed in
hippocampal neurons. They did not differ between Gpr3
+/+ and
Gpr3
2/2 cultures (see Figure S2). The presence of few glial cell
clusters immunostained with an antibody directed against GFAP
(glial fibrillary acidic protein), a marker of astrocytes, was similar in
both genotypes (data not shown). These data indicate an alteration
of cAMP signaling in the CNS of Gpr3
2/2, providing the first
potential link between the receptor constitutive activity and the
behavioral phenotype.
Discussion
The orphan receptor GPR3 is a G protein-coupled receptor
endowed with constitutive Gs signaling activity which is expressed
Figure 5. Alteration in monoamine neurotransmitter levels in
multiple areas in Gpr3
2/2 mice. Tissue content of dopamine (DA),
noradrenaline, (NE), and serotonin, (5-HT) and their metabolites 3-
methoxytyramine (3-MT), homovanillic acid (HVA), normetanephrine
(NM) and 5-hydroxy indolacetic acid (HIAA) were analyzed by HPLC in
the hypothalamus (A), frontal cortex (B), and hippocampus (C) of Gpr3
+/
+ (opens bars) and Gpr3
2/2 mice (black bars). The results are expressed
in pmol/mg protein. Stars indicate significant differences between
Gpr3
+/+ and Gpr3
2/2 mice calculated by the Student t-test (One star
p,0.05, two stars p,0.01, three stars p,0.001, Gpr3
2/2 n=5;Gpr3
+/+
n=6).
doi:10.1371/journal.pone.0004704.g005
Figure 6. Adenylyl cyclase-stimulation properties of GPR3. (A) A
representative experiment is shown. Bars correspond to cAMP
accumulation in CHO cells transfected or not (nTF) with the empty
vector (pcDNA3), GPR3 or I486F TSH (I486F) plasmids and cultured in
serum free medium (F12). The effect of 10 mM S1P (S 1-P) has to be
compared with mock medium (mock). (B) RT-PCR detection of Gpr3
mRNA in primary hippocampal culture of newborn Gpr3
+/+ (+/+) and
Gpr3
2/2 (2/2) mice. Water was added instead of sample to test for
contamination with extraneous DNA (C-). Gapdh (a house keeping
gene) was amplified simultaneously in each cDNA preparation as
internal control. (C) Bars correspond to cAMP accumulation in primary
hippocampal culture of newborn Gpr3
+/+ (+/+) and Gpr3
2/2 mice (2/
2). cAMP levels are expressed in fmoles / 10
6 cells plated 24 h before
measurements. Stars indicate significant differences between Gpr3
+/+
and Gpr3
2/2 mice calculated by the Mann-Withney test (three stars
p,0.001, n=20).
doi:10.1371/journal.pone.0004704.g006
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investigated the consequences of Gpr3 deletion on several
behavioral responses under the control of CNS, in particular the
emotional-like responses.
Gpr3
2/2 mice developed and behaved normally with neither
major changes in locomotion under basal conditions nor
impairment in motor coordination. No deficits in avoidance
learning were evidenced in Gpr3
2/2 mice, which exhibited
similar performance than wild-type mice in the active avoidance
paradigm. This suggests that the lack of GPR3 does not affect
the learning of fear which primarily develops through a
conditioned process. However, Gpr3
2/2 mice exhibited a higher
level of anxiety-related responses after exposure to unfamiliar
stressful environment in the open-field and the elevated plus-
maze paradigms, including a behavioral inhibition observed as a
reduced activity in the open-field test. The anxiety-like
phenotype observed in the elevated plus-maze was sensitive to
the effect of benzodiazepines since the administration of
diazepam reversed the anxiogenic response. In addition, an
increase in the number of attacks and a decrease in the latency
period for the first attack were observed in the resident-intruder
test, revealing a higher level of aggressiveness in mutant mice.
Thus, the behavioral phenotype argues for a possible link
between emotional reactivity and aggressive behavior in mutant
mice [28]. It also suggests that Gpr3
2/2 mice could be more
susceptible to develop a ‘‘depression-related’’ behavior when
exposed to a stressful situation from which they cannot escape.
Indeed Gpr3
2/2 mice exhibited a behavioral despair as
evidenced by an increased duration of immobility in the tail
suspension and the forced swim tests, which are widely used to
assess the efficacy of antidepressant drugs and genetic manipu-
lation relevant to depression. It was suggested that this
acceptance of uncontrollable situation was analogous to the
apathetic despair related to a depressive-like state [27]. We did
not notice any change in serum corticosterone levels in Gpr3
2/2
mice under basal conditions or in response to the stress induced
by the tail suspension test. Therefore, the mechanism underlying
the behavioral characteristics of Gpr3
2/2 mice does not seem to
be related to an alteration of the HPA axis activity. Previous
findings revealed possible dissociation between behavioral
responsiveness and HPA axis activity in various experimental
conditions in rodents [29,30,31,32].
Monoaminergic neurotransmission is thought to modulate
mood states and the stress response. Thereby, important
alterations of the brain monoaminergic systems have been
involved in mood disorders [14,15]. Furthermore, animal studies
proposed an inverse relationship between the activity of the brain
5-HT system and aggressive behavior [33,34,35]. Therefore, we
analyzed the tissue levels of 5-HT, NE and DA in several brain
structures of Gpr3
2/2 mice. We found that Gpr3
2/2 mice exhibit
abnormally low levels of monoamines in various brain areas under
basal conditions. In particular, the dramatic decrease in 5-HT
content observed in hippocampus, hypothalamus and frontal
cortex could well account for the behavioral despair and
aggressiveness displayed by the Gpr3
2/2 mice and indicate a role
for GPR3 in modulating the serotonergic system. The observation
of a significant decrease in NE in cortex and hypothalamus could
also account for the behavioral phenotype of knockout mice.
Because the metabolites of 5-HT and DA were also decreased in
Gpr3
2/2 mice, it seems likely that the primary target of the
regulation by GPR3 is the synthesis or reuptake of these
neurotransmitters. Conversely, in case of NE, the primary
metabolite NM was found to be increased indicating that its
metabolism is affected by Gpr3 deletion.
The expression of GPR3 showed the highest level in the
habenula. The habenular complex is an evolutionarily con-
served diencephalic structurel i n k i n gt h ef o r e b r a i nw i t h
midbrain and hindbrain structures [12,13]. It has been shown
to participate in the regulation of monoamine transmission [12].
Through a habenulo-raphe pathway it modulates serotonergic
activity in many structures including the hippocampus and
influences the noradrenergic activity through a connexion with
the locus coeruleus [36,37]. Our results support this statement
and suggest that such a control is modulated at least in part
through GPR3.
In numerous brain areas, changes in the activity of the cAMP
pathway have been associated with behavioral changes [2,3,4].
Given the ability of GPR3 to activate the cAMP regulatory
cascade in a tonic way, and in agreement with our observation of
lower cAMP levels in primary cultured Gpr3
2/2 neurons, GPR3
effects could be mediated through the cAMP-response-element-
binding protein (CREB). Indeed, the CREB transcription factor
is known to mediate many effects of cAMP on gene expression
and to play a crucial role in depression- and anxiety-related
disorders [2,3,4]. CREB controls the efficacy of synaptic
transmission by regulating the efficiency of neurotransmitter
release from presynaptic terminals [3,4]. The lack of GPR3
could possibly impact on the activity of the efferent connections
of the habenular complex and account for the important
alterations of the brain monoamines that we found in various
brain areas of mutant mice.
Deletion of genes expressed in the medial habenula have been
reported to elicit abnormal anxiety-related behavioral responses,
suggesting that the medial habenula could participate in the
anxiety phenotype observed in the mutant mice [38,39,40]. In
addition, several animal models for despair behavior show an
elevated metabolism in this brain structure [41,42,43,44]. Taken
together our study supports the hypothesis that lack of GPR3
impairs the monoaminergic modulatory function of habenula,
thereby resulting in a reduced ability of Gpr3
2/2 mice to cope with
stress.
Interestingly, mice deficient in phosphodiesterase-4D (PDE-4D)
and animals treated with the PDE-4 inhibitor rolipram display an
attenuated despair behavior when exposed to the same behavioral
models used in the present study [5]. Since GPR3 and PDE-4D
are both highly expressed in medial habenula and have
antagonistic action on the intracellular cAMP level, these data
strengthen the notion that basal levels of cAMP in habenular
neurons are an important parameter for the emotional-like
behaviors under the control of the limbic system [45].
In conclusion, this study demonstrates that GPR3 plays an
important role in modulating several responses in animal models
consistently employed to evaluate emotional disorders including
anxiety, depression-like disorders, and aggressiveness, probably by
tuning the monoaminergic neurotransmission in various brain
regions. In consequence, GPR3 dysfunction could be involved in
the etiology of disorders associated with emotional disturbances,
thereby representing a novel actor of the cAMP-dependent
signaling pathway linked to behavioral responses. Central to this
question is the nature, if any, of the endogenous GPR3 agonist
[46]. From an evolutionary viewpoint and its position in sequence
similarity dendrograms, GPR3 belongs to a subfamily of receptors
in which both peptide and lipid receptors are found [47] and the
lipid sphingosine 1-P has been proposed as a natural GPR3
agonist [10,11]. This has been however questioned [48] and could
not be reproduced in the present study. The possibility must be
considered that receptors with such a strong constitutive activity
might be controlled by natural inverse agonists, or would have no
Gpr3 KO and Behavior.
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would be expected to control regulatory cascades in a tonic way
via the adjustment of their expression level or via the regulation of
their signaling efficacy [51,52]. Identification of the endogenous
ligand(s) of GPR3 or agents capable of modulating its constitutive
activity is expected to open new therapeutic avenues in the
treatments of disorders affecting mood or anxiety.
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detection of Gpr3 mRNA in total brains. As internal controls
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were amplified simultaneously in each cDNA preparation. (B)
Autoradiography of nitrocellulose transferred RT-PCR gel
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